Cargando…

Pharmacological therapies and drug development targeting SARS-CoV-2 infection

The development of therapies for SARS-CoV-2 infection, based on virus biology and pathology, and of large- and small-scale randomized controlled trials, have brought forward several antiviral and immunomodulatory drugs targeting the disease severity. Casirivimab/Imdevimab monoclonal antibodies and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yizhou, Rubin, Limor, Zhou, Zhiwei, Zhang, Haibo, Su, Qiaozhu, Hou, Sheng-Tao, Lazarovici, Philip, Zheng, Wenhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558743/ https://www.ncbi.nlm.nih.gov/pubmed/36266222 http://dx.doi.org/10.1016/j.cytogfr.2022.10.003

Ejemplares similares

Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy
por: Jiang, Yizhou, et al.
Publicado: (2022)

Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity
por: Ge, Lijun, et al.
Publicado: (2022)

Current Progress on Neuroprotection Induced by Artemisia, Ginseng, Astragalus, and Ginkgo Traditional Chinese Medicines for the Therapy of Alzheimer's Disease
por: Li, Qin, et al.
Publicado: (2022)

Autoimmune phenomena following SARS-CoV-2 vaccination
por: Ishay, Yuval, et al.
Publicado: (2021)

Interaction between Sars-CoV-2 structural proteins and host cellular receptors: From basic mechanisms to clinical perspectives
por: Wade, Henry, et al.
Publicado: (2022)

Anti-inflammatory Effects of Traditional Chinese Medicines on Preclinical in vivo Models of Brain Ischemia-Reperfusion-Injury: Prospects for Neuroprotective Drug Discovery and Therapy
por: Peng, Tangming, et al.
Publicado: (2019)

The Neuroimmune Pharmacology of SARS-CoV-2
por: Kumar, Santosh, et al.
Publicado: (2021)

Signaling Network of Forkhead Family of Transcription Factors (FOXO) in Dietary Restriction
por: Jiang, Yizhou, et al.
Publicado: (2019)

Anti–SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology Considerations
por: Zhang, Xinyuan, et al.
Publicado: (2021)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Molecular pharmacology of ciclesonide against SARS-CoV-2
por: Kimura, Hirokazu, et al.
Publicado: (2020)

Potential therapeutic and pharmacological strategies for SARS-CoV2
por: Ghareeb, Doaa A., et al.
Publicado: (2021)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing
por: Krishnamoorthy, Pandikannan, et al.
Publicado: (2021)

What Binds Cationic Photosensitizers Better: Brownian Dynamics Reveals Key Interaction Sites on Spike Proteins of SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Fedorov, Vladimir, et al.
Publicado: (2021)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

The Envelope (E) Protein of SARS-CoV-2 as a Pharmacological Target
por: Santos-Mendoza, Teresa
Publicado: (2023)

SARS-CoV-2 Antiviral Therapy
por: Tao, Kaiming, et al.
Publicado: (2021)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022)

Drug Discovery Strategies for SARS-CoV-2
por: Shyr, Zeenat A., et al.
Publicado: (2020)

Immunomodulatory Drugs in the Management of SARS-CoV-2
por: Burrage, Daniel R., et al.
Publicado: (2020)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
por: Zhou, Yadi, et al.
Publicado: (2020)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
por: Ezhilan, Madeshwari, et al.
Publicado: (2021)

A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
por: Zhou, Huan, et al.
Publicado: (2021)

Pristimerin‐induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway
por: Yan, Fengxia, et al.
Publicado: (2020)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro
por: Hou, Ningke, et al.
Publicado: (2023)

Drug discovery and development targeting the life cycle of SARS-CoV-2
por: Su, Haixia, et al.
Publicado: (2021)

Analysis and Identification of Bioactive Compounds of Cannabinoids in Silico for Inhibition of SARS-CoV-2 and SARS-CoV
por: Chen, Chenxiao, et al.
Publicado: (2022)

SARS-CoV-2 pharmacologic therapies and their safety/effectiveness according to level of evidence
por: Baroutjian, Amanda, et al.
Publicado: (2020)

Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication
por: Chu, Junjun, et al.
Publicado: (2021)

Computational and network pharmacology studies of Phyllanthus emblica to tackle SARS-CoV-2
por: Chikhale, Rupesh V., et al.
Publicado: (2021)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
por: Abdelghany, T.M., et al.
Publicado: (2021)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_30shq0s7mqr18jk5rgopirgt3d